Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Long-Term Reduction in CRC Risk After Negative Colonoscopy
MONDAY, Dec. 31, 2018 (HealthDay News) — For average-risk patients, a negative colonoscopy result is associated with a long-term reduction in the risk for colorectal cancer and related deaths, according to a study published online Dec. 17 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
New Guidelines Address Care for Malignant Pleural Effusions
FRIDAY, Dec. 28, 2018 (HealthDay News) — New clinical practice guidelines for the management of malignant pleural effusions were published in the January issue of the Annals of the American Thoracic Society.
Abstract/Full Text (subscription or payment may be required)
Many Veterans Oppose Cessation of Colorectal Cancer Screening
FRIDAY, Dec. 28, 2018 (HealthDay News) — Many veterans have strong preferences against colorectal cancer (CRC) screening cessation even when provided with information about the potential low benefit of screening, according to a study published online Dec. 7 in JAMA Network Open.
Risk for Breast Cancer Increased With False-Positive Screening Result
FRIDAY, Dec. 28, 2018 (HealthDay News) — Women with prior false-positive screening results have an increased risk for screen-detected and interval breast cancer for more than 10 years, according to a study published online Dec. 18 in the British Journal of Cancer.
Abstract/Full Text (subscription or payment may be required)
Obese Patients Exposed to Higher Radiation Doses for X-Rays
FRIDAY, Dec. 28, 2018 (HealthDay News) — Patients with obesity undergoing projection radiography receive a higher dose area product (DAP) than normal-weight adults, according to a study published online Dec. 20 in the Journal of Radiological Protection.
Targeted Muscle Reinnervation Can Reduce Phantom Limb Pain
THURSDAY, Dec. 27, 2018 (HealthDay News) — Use of primary targeted muscle reinnervation (TMR) can prevent or reduce pain in below-the-knee amputees, according to a report published online Dec. 27 in Plastic and Reconstructive Surgery.
Abstract/Full Text (subscription or payment may be required)
Low-Priced Generic Drugs Most Likely to Have Shortages
THURSDAY, Dec. 27, 2018 (HealthDay News) — The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.
Abstract/Full Text (subscription or payment may be required)
Elevated Risk for Lung CA in Lung Transplant Recipients Explored
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome 
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race 
Few Young Adults Receive Palliative Care as Part of Advanced Cancer Treatment 
Emergency Presentation of Cancer Common in Older Adults .jpg)
Remote Patient-Reported Outcome Monitoring Empowers Patients With Cancer 
Tobacco Treatment Program Effective in Oncology Settings 
Odds of HPV-Related Cancers Up for People With HIV, Solid Organ Transplant Recipients 
